SNCE — Science 37 Holdings Income Statement
0.000.00%
Last trade - 00:00- $34.54m
- -$21.87m
- $70.15m
- 35
- 62
- 21
- 32
Annual income statement for Science 37 Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 23.7 | 59.6 | 70.1 |
| Cost of Revenue | |||
| Gross Profit | 1.11 | 17.2 | 15.9 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 56.2 | 123 | 222 |
| Operating Profit | -32.5 | -63.7 | -152 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -31.7 | -94.3 | -51.1 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -31.7 | -94.3 | -51 |
| Net Income Before Extraordinary Items | |||
| Net Income | -31.7 | -94.3 | -51 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -31.7 | -94.3 | -51 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -5.35 | -16.3 | -3.56 |